Recombinant Human XPA Protein，His & GST

XPA, or Xeroderma Pigmentosum group A protein, is a crucial component of the nucleotide excision repair (NER) pathway, which is responsible for removing DNA lesions caused by environmental factors such as UV radiation and chemical exposure. Deficiencies in XPA lead to xeroderma pigmentosum, a rare genetic disorder characterized by extreme sensitivity to sunlight and a heightened risk of skin cancers due to the inability to effectively repair DNA damage. Research on XPA recombinant protein has gained significant attention as it allows for the detailed study of its structure, function, and interactions with other proteins involved in the NER pathway. Such studies have been instrumental in elucidating the molecular mechanisms underlying DNA repair and the biological implications of XPA mutations. Furthermore, producing XPA in recombinant form enables researchers to investigate potential therapeutic interventions and enhance our understanding of cancer prevention strategies. As a model system for studying DNA repair processes, the recombinant XPA protein provides invaluable insights into the complex interactions within the NER pathway and offers potential avenues for the development of gene-targeted therapies, thereby addressing both fundamental biological questions and practical applications in medicine.